These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8268386)

  • 1. Chitosan matrix for oral sustained delivery of ampicillin.
    Chandy T; Sharma CP
    Biomaterials; 1993 Oct; 14(12):939-44. PubMed ID: 8268386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan beads and granules for oral sustained delivery of nifedipine: in vitro studies.
    Chandy T; Sharma CP
    Biomaterials; 1992; 13(13):949-52. PubMed ID: 1477265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of liposome-albumin coatings on ferric ion retention and release from chitosan beads.
    Chandy T; Sharma CP
    Biomaterials; 1996 Jan; 17(1):61-6. PubMed ID: 8962949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug release behavior of beads and microgranules of chitosan.
    Gupta KC; Ravi Kumar MN
    Biomaterials; 2000 Jun; 21(11):1115-9. PubMed ID: 10817263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of chitosan/polyethylene vinyl acetate co-matrix: controlled release of aspirin-heparin for preventing cardiovascular thrombosis.
    Vasudev SC; Chandy T; Sharma CP
    Biomaterials; 1997 Mar; 18(5):375-81. PubMed ID: 9061177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of poly(Lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis.
    Chandy T; Rao GH; Wilson RF; Das GS
    Drug Deliv; 2001; 8(2):77-86. PubMed ID: 11400866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of ampicillin loaded methylpyrrolidinone chitosan and chitosan microspheres.
    Giunchedi P; Genta I; Conti B; Muzzarelli RA; Conte U
    Biomaterials; 1998; 19(1-3):157-61. PubMed ID: 9678863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin.
    Hari PR; Chandy T; Sharma CP
    J Microencapsul; 1996; 13(3):319-29. PubMed ID: 8860687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral theophylline sustained-release beads.
    Aiedeh K; Taha MO
    Eur J Pharm Sci; 2001 May; 13(2):159-68. PubMed ID: 11297900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of melatonin-loaded stearyl alcohol microspheres.
    Lee BJ; Choe JS; Kim CK
    J Microencapsul; 1998; 15(6):775-87. PubMed ID: 9818955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin.
    Anal AK; Stevens WF; Remuñán-López C
    Int J Pharm; 2006 Apr; 312(1-2):166-73. PubMed ID: 16497452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release characteristics of chitosan treated alginate beads: II. Sustained release of a low molecular drug from chitosan treated alginate beads.
    Sezer AD; Akbuğa J
    J Microencapsul; 1999; 16(6):687-96. PubMed ID: 10575621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery.
    Shu XZ; Zhu KJ
    Int J Pharm; 2000 May; 201(1):51-8. PubMed ID: 10867264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide.
    Ganza-González A; Anguiano-Igea S; Otero-Espinar FJ; Blanco Méndez J
    Eur J Pharm Biopharm; 1999 Sep; 48(2):149-55. PubMed ID: 10469933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable chitosan matrix for the controlled release of steroids.
    Chandy T; Sharma CP
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(4):745-60. PubMed ID: 1810408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buoyant sustained release granules based on chitosan.
    Inouye K; Machida Y; Sannan T; Nagai T
    Drug Des Deliv; 1989 Jan; 4(1):55-67. PubMed ID: 2775446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical characteristics and release behavior of salbutamol sulfate beads prepared with different ionic polysaccharides.
    el Fattah EA; Grant DJ; Gabr KE; Meshali MM
    Drug Dev Ind Pharm; 1998 Jun; 24(6):541-7. PubMed ID: 9876620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The controlled release of a drug from biodegradable chitosan gel beads.
    Kofuji K; Ito T; Murata Y; Kawashima S
    Chem Pharm Bull (Tokyo); 2000 Apr; 48(4):579-81. PubMed ID: 10783085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of biodegradable sponges as controlled release drug matrices. I. Effect of moisture level on chitosan sponge mechanical properties.
    Foda NH; El-laithy HM; Tadros MI
    Drug Dev Ind Pharm; 2004 Apr; 30(4):369-79. PubMed ID: 15132179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery.
    Senel S; Ikinci G; Kaş S; Yousefi-Rad A; Sargon MF; Hincal AA
    Int J Pharm; 2000 Jan; 193(2):197-203. PubMed ID: 10606782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.